glp 1 vs sglt2 diabetes GLP-1 Receptor Agonist Therapy With and Without Inhibitors in Patients With Type 2 Differential effects of SGLT1 and

Impact of GLP-1 Drug Adoption on Consumer Food Demand GLP-1 weight loss drugs are likely to impact long-term category growth rates for food consumption

Each impacts safety and outcomes differently and requires a well-defined monitoring and mitigation plan

Macrophage Foaming: TMAO Promotes the Conversion of Macrophages Into Foam Cells As the major immune cells in atherosclerotic lesions, macrophages play a critical role in the development of atherosclerosis

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)

The gastrointestinal effects of allulose are dose-dependent and vary considerably between individuals